This is the list of the largest public listed companies in the Biotechnology industry from Switzerland by market capitalization with links to their reference stock.
Company Profile:
CRISPR Therapeutics AG
Market Cap (USD):
$4.51 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
BB Biotech AG
Market Cap (USD):
$2.12 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Kuros Biosciences AG
Market Cap (USD):
$1.37 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Idorsia Ltd
Market Cap (USD):
$598.0 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
VectivBio Holding AG
Market Cap (USD):
$474.9 M
(Jan. 1, 2023)
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
ADC Therapeutics SA
Market Cap (USD):
$282.8 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
AC Immune SA
Market Cap (USD):
$208.2 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Santhera Pharmaceuticals Holding AG
Market Cap (USD):
$197.2 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Xlife Sciences AG
Market Cap (USD):
$145.1 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Molecular Partners AG
Market Cap (USD):
$139.9 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
NLS Pharmaceutics AG
Market Cap (USD):
$12.0 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology